Advertisement
UK markets close in 5 hours 45 minutes
  • FTSE 100

    8,087.28
    +46.90 (+0.58%)
     
  • FTSE 250

    19,725.48
    +6.11 (+0.03%)
     
  • AIM

    755.15
    +0.46 (+0.06%)
     
  • GBP/EUR

    1.1671
    +0.0026 (+0.22%)
     
  • GBP/USD

    1.2521
    +0.0059 (+0.47%)
     
  • Bitcoin GBP

    51,037.10
    -1,952.90 (-3.69%)
     
  • CMC Crypto 200

    1,363.93
    -18.65 (-1.35%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.72
    -0.09 (-0.11%)
     
  • GOLD FUTURES

    2,337.20
    -1.20 (-0.05%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,981.18
    -107.52 (-0.59%)
     
  • CAC 40

    8,048.67
    -43.19 (-0.53%)
     

Teva Stock Has Risen Significantly since November Lows: What’s Next?

Teva Stock Has Risen Significantly since November Lows: What’s Next?

Teva Pharmaceuticals released its 3Q17 earnings results on November 2, 2017. The disappointing earnings and the company’s lowering of its fiscal 2017 guidance triggered negative investor sentiments, which led to a massive decline of approximately 20% in TEVA stock prices. The company has run into troubles over the past year and it reported a dismal performance in 3Q17. For details, read, Inside Teva’s 3Q17 Performance.